These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Differential modulation of angiotensin II and hypertonic saline-induced drinking by opioid receptor subtype antagonists in rats. Ruegg H; Hahn B; Koch JE; Bodnar RJ Brain Res; 1994 Jan; 635(1-2):203-10. PubMed ID: 8173956 [TBL] [Abstract][Full Text] [Related]
11. A study of the effect of the irreversible delta receptor antagonist [D-Ala2,Leu5,Cys6]-enkephalin on delta cx and delta ncx opioid binding sites in vitro and in vivo. Rothman RB; Bykov V; Jacobson AE; Rice KC; Long JE; Bowen WD Peptides; 1992; 13(4):691-4. PubMed ID: 1331996 [TBL] [Abstract][Full Text] [Related]
12. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site. Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752 [TBL] [Abstract][Full Text] [Related]
13. Stress-induced tolerance to delta receptor agonist DPDPE and selectivity of the irreversible delta-ligand, DALCE. Calcagnetti DJ; Bowen WD; Holtzman SG Brain Res; 1990 Feb; 509(2):205-12. PubMed ID: 2157520 [TBL] [Abstract][Full Text] [Related]
14. Mediation of insulin hyperphagia by specific central opiate receptor antagonists. Beczkowska IW; Bodnar RJ Brain Res; 1991 May; 547(2):315-8. PubMed ID: 1653080 [TBL] [Abstract][Full Text] [Related]
15. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes. Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319 [TBL] [Abstract][Full Text] [Related]
16. Central opioid receptor subtype mediation of isoproterenol-induced drinking in rats. Glass MJ; Hahn B; Joseph A; Bodnar RJ Brain Res; 1994 Sep; 657(1-2):310-4. PubMed ID: 7820634 [TBL] [Abstract][Full Text] [Related]
17. Mu-delta opioid interactions. III: Differential antagonism of DPDPE-induced increases in morphine EEG and EEG power spectra by DALCE and naltrindole. Stamidis H; Young GA Peptides; 1993; 14(3):511-7. PubMed ID: 8392719 [TBL] [Abstract][Full Text] [Related]
18. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Cole JL; Leventhal L; Pasternak GW; Bowen WD; Bodnar RJ Brain Res; 1995 Apr; 678(1-2):168-76. PubMed ID: 7620885 [TBL] [Abstract][Full Text] [Related]
19. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Bodnar RJ; Glass MJ; Ragnauth A; Cooper ML Brain Res; 1995 Nov; 700(1-2):205-12. PubMed ID: 8624711 [TBL] [Abstract][Full Text] [Related]
20. Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats. Beczkowska IW; Bowen WD; Bodnar RJ Brain Res; 1992 Sep; 589(2):291-301. PubMed ID: 1327413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]